The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment
Open accessAbstract
An estimated 300 million people are affected by asthma worldwide and the burden is likely to rise substantially in the next few decades. Estimates of the prevalence of asthma range from 7% in France and Germany to 11% in the USA and 15-18% in the United Kingdom. Approximately 20% of these patients have severe asthma, of which 20% is inadequately controlled. Patients with inadequately controlled severe persistent asthma are at a particularly high risk of exacerbations, hospitalization and death, and often have severely impaired quality of life. Current management of asthma focuses on a stepwise approach tailored to disease severity. In addition to needing high-dose inhaled corticosteroids (ICS) and long-acting beta(2)-agonists (LABAs), patients with severe persistent asthma often require additional controller medications, such as anti-leukotrienes, oral LABAs, oral corticosteroids and/or anti-IgE therapy. There is currently little evidence on which to base treatment decisions in patients with inadequately controlled severe persistent asthma already treated with ICS and LABAs. The anti-IgE monoclonal antibody omalizumab is the most recent addition to the list of treatment options for these patients and has been shown to reduce exacerbations and emergency visits and improve lung function, symptom scores and quality of life in patients with difficult-to-treat asthma whose symptoms remain inadequately controlled despite receiving ICS and LABAs. Comparative trials are needed to determine the merits of different treatments and strategies for patients with inadequately controlled severe persistent asthma and to identify patients likely to benefit from new treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Allergy: Principles and Practice.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_10 · Cited by 1,696
Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., & Pedersen, S. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-033oc · Cited by 1,594
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J., Beeh, K. ‐., Ramos, S., Canonica, G. W., Hedgecock, S., et al. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00772.x · Cited by 1,123
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study
Rabe, K., Vermeire, P., Soriano, J., & Maier, W. (2000) · European Respiratory Journal · doi:10.1183/09031936.00.16580200 · Cited by 1,025
Greening, A. P., Ind, P. W., Northfield, M., & Shaw, G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92996-3 · Cited by 972
Rabe, K. F., Adachi, M., Lai, C. K. W., Soriano, J. B., Vermeire, P. A., Weiss, K. B., & Weiss, S. T. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.042 · Cited by 943
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
(1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380222 · Cited by 864
Flood-Page, P. T., Menzies-Gow, A. N., Kay, A. B., & Robinson, D. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-789oc · Cited by 808
The ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
WENZEL, S. E., SZEFLER, S. J., LEUNG, D. Y. M., SLOAN, S. I., REX, M. D., & MARTIN, R. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9610046 · Cited by 754
Woolcock, A., Lundback, B., Ringdal, N., & Jacques, L. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630590 · Cited by 701
Djukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 646
Distinguishing severe asthma phenotypes
Miranda, C., Busacker, A., Balzar, S., Trudeau, J., & Wenzel, S. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.041 · Cited by 586
Kips, J. C., O'Connor, B. J., Langley, S. J., Woodcock, A., Kerstjens, H. A. M., Postma, D. S., Danzig, M., Cuss, F., & Pauwels, R. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-525oc · Cited by 494
Kitler, M. E. (2005) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200519040-00007 · Cited by 480
Leynaert, B., Bousquet, J., Neukirch, C., Liard, R., & Neukirch, F. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70370-2 · Cited by 453
The European Community Respiratory Health Survey: what are the main results so far?
Janson, C., Anto, J., Burney, P., Chinn, S., de Marco, R., Heinrich, J., Jarvis, D., Kuenzli, N., Leynaert, B., Luczynska, C., et al. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00205801 · Cited by 451
Vignola, A. M., Humbert, M., Bousquet, J., Boulet, L., Hedgecock, S., Blogg, M., Fox, H., & Surrey, K. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00550.x · Cited by 405
Bousquet, J., Cabrera, P., Berkman, N., Buhl, R., Holgate, S., Wenzel, S., Fox, H., Hedgecock, S., Blogg, M., & Cioppa, G. D. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00770.x · Cited by 401
Costs of asthma according to the degree of severity
Serra-Batlles, J., Plaza, V, Morejon, E., Comella, A., & Brugues, J. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061322 · Cited by 387
Ers Task Force on Difficult/therapy-Resistant Asthma, & Members of the Task Force: K.F. Chung and P. Godard (co-chairmen), E. A. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13e43.x · Cited by 351
Crystal-Peters, J., Neslusan, C., Crown, W. H., & Torres, A. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.120554 · Cited by 350
Costs of asthma are correlated with severity: a 1-yr prospective study
Godard, P., Chanez, P., Siraudin, L., Nicoloyannis, N., & Duru, G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00232001 · Cited by 331
Wenzel, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1181pp · Cited by 309
Asthma severity and medical resource utilisation
Antonicelli, L., Bucca, C., Neri, M., De Benedetto, F., Sabbatani, P., Bonifazi, F., Eichler, H., Zhang, Q., & Yin, D. D. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00004904 · Cited by 290
Systematic assessment of difficult-to-treat asthma
Robinson, D. S., Campbell, D. A., Durham, S. R., Pfeffer, J., Barnes, P. J., & Chung, K. F. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00017003 · Cited by 289
Dolan, C. M., Fraher, K. E., Bleecker, E. R., Borish, L., Chipps, B., Hayden, M. L., Weiss, S., Zheng, B., Johnson, C., & Wenzel, S. (2004) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61707-3 · Cited by 287
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
Bousquet, J., Wenzel, S., Holgate, S., Lumry, W., Freeman, P., & Fox, H. (2004) · Chest · doi:10.1378/chest.125.4.1378 · Cited by 277
Risk Factors for Near-fatal Asthma: A Case–Control Study in Hospitalized Patients with Asthma
TURNER, M. O., NOERTJOJO, K., VEDAL, S., BAI, T., CRUMP, S., & MARK FITZGERALD, J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9708092 · Cited by 275
Weinberger, M., & Hendeles, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342107 · Cited by 274
Theophylline in the management of asthma: time for reappraisal?
Barnes, P. J., & Pauwels, R. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07030579 · Cited by 272
Airway Hyperresponsiveness in Allergic Rhinitis
Braman, S. S., Barrows, A. A., DeCotiis, B. A., Settipane, G. A., & Corrao, W. M. (1987) · Chest · doi:10.1378/chest.91.5.671 · Cited by 256
Relationship between quality of life and clinical status in asthma: a factor analysis
Juniper, E. F., Wisniewski, M. E., Cox, F. M., Emmett, A. H., Nielsen, K. E., & O'Byrne, P. M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00064204 · Cited by 238
Intranasal steroids and the risk of emergency department visits for asthma
Adams, R. J., Fuhlbrigge, A. L., Finkelstein, J. A., & Weiss, S. T. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123237 · Cited by 226
Barnes, P., & Woolcock, A. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12051209 · Cited by 225
Wright, R. J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.050 · Cited by 217
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
CHRISTIAN VIRCHOW, J., PRASSE, A., NAYA, I., SUMMERTON, L., HARRIS, A., & The Zafirlukast Study Group (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9905041 · Cited by 215
Clinical review: severe asthma.
Papiris, S. A., Kotanidou, A. N., Malagari, K. S., & Roussos, C. (2002) · Critical Care · doi:10.1186/cc1451 · Cited by 213
Allergy: Principles and Practice.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-2-328_2 · Cited by 212
Effect of a concomitant diagnosis of allergic rhinitis on asthma‐related health care use by adults
Price, D., Zhang, Q., Kocevar, V. S., Yin, D. D., & Thomas, M. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02182.x · Cited by 205
Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol
Heaney, L. G. (2003) · Thorax · doi:10.1136/thorax.58.7.561 · Cited by 192
Risk factors and costs associated with an asthma attack
Hoskins, G. (2000) · Thorax · doi:10.1136/thorax.55.1.19 · Cited by 189
Obesity and Asthma: Directions for Research
Weiss, S. T., & Shore, S. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-403ws · Cited by 186
Hochhaus, G., Brookman, L., Fox, H., Johnson, C., Matthews, J., Ren, S., & Deniz, Y. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002171 · Cited by 181
Self-citationBrinke, A. T., van Dissel, J. T., Sterk, P. J., Zwinderman, A. H., Rabe, K. F., & Bel, E. H. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113047 · Cited by 160
Robinson, D. S., Campbell, D., & Barnes, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05113-8 · Cited by 159
Tamaoki, J., Kondo, M., Sakai, N., Tagaya, E., Nakata, J., Isono, K., Nagai, A., & Aoshiba, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02501-0 · Cited by 133
Holgate, S. T., Bousquet, J., Wenzel, S. E., Fox, H., Liu, J., & Castellsagué, J. (2001) · Current Medical Research and Opinion · doi:10.1185/0300799019117010 · Cited by 125
Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions
Büttner, C., Lun, A., Splettstoesser, T., Kunkel, G., & Renz, H. E. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00027302 · Cited by 120
Methotrexate as a steroid sparing agent for asthma in adults
Davies, H. R. H. R., Olson, L. G., & Gibson, P. G. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000391 · Cited by 102
Treatment of steroid-dependent bronchial asthma with cyclosporin
Nizankowska, E., Soja, J., Pinis, G., Bochenek, G., Sładek, K., Domagala, B., Pajak, A., & Szczeklik, A. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08071091 · Cited by 96
Fagan, J. K., Galea, S., Ahern, J., Bonner, S., & Vlahov, D. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097334.48556.5f · Cited by 92
Coping as a mediator of psychosocial impediments to optimal management and control of asthma
Barton, C., Clarke, D., Sulaiman, N., & Abramson, M. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)00029-5 · Cited by 91
Predictors of Poor Asthma Control in European Adults
Soriano, J. B., Rabe, K. F., & Vermeire, P. A. (2003) · Journal of Asthma · doi:10.1081/jas-120023572 · Cited by 76
Assessment of asthma control and severity
Vollmer, W. M. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61406-8 · Cited by 71
Davies, B., Brooks, G. D., & Devoy, M. A. B. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90105-6 · Cited by 64
Features That Distinguish those who Die from Asthma from Community Controls with Asthma
Tough, S., Hessel, P. A., Ruff, M., Green, F. H. Y., Mitchell, I., & Butt, J. C. (1998) · Journal of Asthma · doi:10.3109/02770909809048968 · Cited by 64
Hartert, T. V., Speroff, T., Togias, A. G., et al. (2002) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62083-2 · Cited by 62
Asthma and body weight change: a 20-year prospective community study of young adults
Hasler, G., Gergen, P. J., Ajdacic‐Gross, V., Gamma, A., Eich, D., Wulf Rössler, A., & Angst, J. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803215 · Cited by 57
Effect of asthma on quality of life.
Juniper, E. F. (1998) · PubMed · Cited by 50
Effect of intranasal corticosteroid treatment on asthma in children and adults
Durham, S. R. (1999) · Allergy · doi:10.1111/j.1398-9995.1999.tb04414.x · Cited by 28
Cited by
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
FitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
Self-citationWenzel, S., Castro, M., Corren, J., Maspero, J., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E. R., Evans, R. R., Joish, V. N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30307-5 · Cited by 985
Gibson, P. G., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., Peters, M. J., Marks, G. B., Baraket, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31281-3 · Cited by 662
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Piper, E., Brightling, C., Niven, R., Oh, C., Faggioni, R., Poon, K., She, D., Kell, C., May, R. D., Geba, G. P., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00223411 · Cited by 373
Metadata
- Authors
- Peters, S. P., Ferguson, G., Deniz, Y., & Reisner, C.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 100
- Issue
- 7
- Pages
- 1139-1151
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W2064243251
- Cited by
- 320
- References
- 67
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.